DYNLT5

gene
On this page

Also known as FLJ40873

Summary

DYNLT5 (dynein light chain Tctex-type family member 5, HGNC:26882) is a protein-coding gene on chromosome 1p31.3, encoding Dynein light chain Tctex-type 5 (Q8N7M0).

Predicted to enable dynein intermediate chain binding activity. Predicted to be involved in microtubule-based movement. Predicted to be part of cytoplasmic dynein complex. Predicted to be active in cytoplasm.

Source: NCBI Gene 200132 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 37 total
  • MANE Select transcript: NM_152665

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26882
Approved symbolDYNLT5
Namedynein light chain Tctex-type family member 5
Location1p31.3
Locus typegene with protein product
StatusApproved
AliasesFLJ40873
Ensembl geneENSG00000152760
Ensembl biotypeprotein_coding
OMIM619994
Entrez200132

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 3 protein_coding, 2 protein_coding_CDS_not_defined, 2 retained_intron, 1 nonsense_mediated_decay

ENST00000282670, ENST00000448074, ENST00000489510, ENST00000491611, ENST00000525663, ENST00000528352, ENST00000909939, ENST00000909940

RefSeq mRNA: 1 — MANE Select: NM_152665 NM_152665

CCDS: CCDS633

Canonical transcript exons

ENST00000282670 — 5 exons

ExonStartEnd
ENSE000012582666677038766770478
ENSE000012582816677725166779047
ENSE000021483926675245966752584
ENSE000035469146675465666754777
ENSE000036019346677627966776403

Expression profiles

Bgee: expression breadth ubiquitous, 183 present calls, max score 99.31.

FANTOM5 (CAGE): breadth broad, TPM avg 2.1942 / max 302.5122, expressed in 452 samples.

FANTOM5 promoters (8 alternative TSS)

Promoter IDTPM avgSamples expressed
33830.6141253
33770.517663
33840.4411179
33800.172135
33810.164245
33790.150130
33780.088929
33820.046217

Top tissues by expression

240 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right uterine tubeUBERON:000130299.31gold quality
oviduct epitheliumUBERON:000480492.53gold quality
bronchial epithelial cellCL:000232892.52gold quality
bronchusUBERON:000218590.81gold quality
olfactory segment of nasal mucosaUBERON:000538687.83gold quality
fallopian tubeUBERON:000388985.40gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.53gold quality
hypothalamusUBERON:000189884.26gold quality
right lungUBERON:000216782.43gold quality
mucosa of paranasal sinusUBERON:000503082.20gold quality
apex of heartUBERON:000209882.15gold quality
endothelial cellCL:000011580.65silver quality
epithelium of nasopharynxUBERON:000195178.59gold quality
caudate nucleusUBERON:000187378.56gold quality
Brodmann (1909) area 9UBERON:001354078.35gold quality
right frontal lobeUBERON:000281078.22gold quality
heart left ventricleUBERON:000208477.07gold quality
upper lobe of left lungUBERON:000895276.70gold quality
endocervixUBERON:000045876.47gold quality
cardiac ventricleUBERON:000208276.29gold quality
right lobe of liverUBERON:000111475.35gold quality
dorsolateral prefrontal cortexUBERON:000983475.30gold quality
upper lobe of lungUBERON:000894875.23gold quality
anterior cingulate cortexUBERON:000983575.20gold quality
buccal mucosa cellCL:000233674.76silver quality
amygdalaUBERON:000187674.21gold quality
lower esophagusUBERON:001347373.91gold quality
lower esophagus muscularis layerUBERON:003583373.91gold quality
heartUBERON:000094873.85gold quality
tibial nerveUBERON:000132373.80gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-ANND-3yes8.02
E-MTAB-9388yes7.81

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

75 targeting DYNLT5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3646100.0073.565283
HSA-MIR-188-3P100.0068.761240
HSA-MIR-511-3P99.9968.851467
HSA-MIR-186-5P99.9970.833707
HSA-MIR-569699.9872.364487
HSA-MIR-485-3P99.9870.681585
HSA-MIR-539-3P99.9870.741616
HSA-MIR-548N99.9871.944170
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-4760-3P99.9370.502385
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-4753-3P99.9071.033786
HSA-MIR-153-5P99.8973.866317
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-106B-5P99.8874.722795
HSA-MIR-20A-5P99.8874.762769
HSA-MIR-5582-3P99.8672.484221
HSA-MIR-579-3P99.8671.663628
HSA-MIR-629-3P99.8567.991875
HSA-MIR-664B-3P99.8471.653590
HSA-MIR-5010-3P99.8370.602357
HSA-MIR-130B-5P99.8368.501888
HSA-MIR-548AZ-5P99.8369.943230
HSA-MIR-548T-5P99.8369.913220
HSA-MIR-4639-5P99.8167.371028
HSA-MIR-57799.7869.132479
HSA-MIR-4713-5P99.7867.801794
HSA-MIR-472999.6972.184233
HSA-MIR-453099.6966.471509

Literature-anchored findings (GeneRIF, showing 1)

  • TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy. (PMID:31896777)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriodynlt5ENSDARG00000103545
mus_musculusDynlt5ENSMUSG00000028523
rattus_norvegicusDynlt5ENSRNOG00000023100

Paralogs (5): DYNLT1 (ENSG00000146425), DYNLT3 (ENSG00000165169), DYNLT2 (ENSG00000184786), DYNLT4 (ENSG00000188396), DYNLT2B (ENSG00000213123)

Protein

Protein identifiers

Dynein light chain Tctex-type 5Q8N7M0 (reviewed: Q8N7M0)

Alternative names: Tctex1 domain-containing protein 1

All UniProt accessions (2): Q8N7M0, E9PI84

UniProt curated annotations — full annotation on UniProt →

Subunit / interactions. Interacts with ZMYND10.

Similarity. Belongs to the dynein light chain Tctex-type family.

Isoforms (2)

UniProt IDNamesCanonical?
Q8N7M0-11yes
Q8N7M0-22

RefSeq proteins (1): NP_689878* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR005334Tctex-1-likeFamily
IPR038586Tctex-1-like_sfHomologous_superfamily

Pfam: PF03645

UniProt features (3 total): sequence variant 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8N7M0-F177.940.58

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-5620924Intraflagellar transport

MSigDB gene sets: 108 (showing top): SHEPARD_BMYB_MORPHOLINO_UP, GTTAAAG_MIR302B, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN, TGGAAA_NFAT_Q4_01, ZHENG_BOUND_BY_FOXP3, GOCC_CYTOPLASMIC_DYNEIN_COMPLEX, GOCC_DYNEIN_COMPLEX, GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D, DODD_NASOPHARYNGEAL_CARCINOMA_DN, GCTCTTG_MIR335, NOUSHMEHR_GBM_SILENCED_BY_METHYLATION, GOMF_DYNEIN_INTERMEDIATE_CHAIN_BINDING, REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE, REACTOME_CILIUM_ASSEMBLY

GO Biological Process (1): microtubule-based movement (GO:0007018)

GO Molecular Function (2): dynein intermediate chain binding (GO:0045505), protein binding (GO:0005515)

GO Cellular Component (2): cytoplasm (GO:0005737), cytoplasmic dynein complex (GO:0005868)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Assembly of the 9+0 primary cilium1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
microtubule-based process1
protein binding1
binding1
intracellular anatomical structure1
cellular anatomical structure1
dynein complex1

Protein interactions and networks

STRING

593 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
DYNLT5DNAI4Q5VTH9611
DYNLT5DNAI2Q9GZS0598
DYNLT5SSUH2Q9Y2M2527
DYNLT5DYNLT1P63172517
DYNLT5TMEM89A2RUT3507
DYNLT5ANKUB1A6NFN9495
DYNLT5DYNLRB2Q8TF09485
DYNLT5DYNC1LI2O43237483
DYNLT5GTF2A1P52655478
DYNLT5DNAL4O96015468
DYNLT5DYNC1I1O14576457
DYNLT5LRRC71Q8N4P6455
DYNLT5DYNC1LI1Q9Y6G9452
DYNLT5DYNLT3P51808444
DYNLT5LTBP4Q8N2S1434
DYNLT5SGIP1Q9BQI5434

IntAct

6 interactions, top by confidence:

ABTypeScore
MEOX2DYNLT5psi-mi:“MI:0915”(physical association)0.560
DYNLT5MEOX2psi-mi:“MI:0915”(physical association)0.560
DYNLT5GAPDHSpsi-mi:“MI:0915”(physical association)0.400
DYNLT5SVILpsi-mi:“MI:0914”(association)0.350

BioGRID (9): TCTEX1D1 (Two-hybrid), RBMXL1 (Affinity Capture-MS), SVIL (Affinity Capture-MS), PPP1R9A (Affinity Capture-MS), LIMA1 (Affinity Capture-MS), ITPR3 (Affinity Capture-MS), GAPDHS (Affinity Capture-MS), NME2 (Cross-Linking-MS (XL-MS)), NME1 (Cross-Linking-MS (XL-MS))

ESM2 similar proteins: A2A2Y4, A2VDD2, A7MBL8, B2RQE8, B9EJ86, D4A1F2, E9Q4Z2, E9Q5G3, F1MF74, F1ND48, F1QDI9, G9CGD6, O00763, O08874, O94851, O95630, P0C928, P78563, Q0P4Q4, Q0VGY8, Q16513, Q2TBH6, Q3B8D7, Q498D5, Q4U2V3, Q5R803, Q62698, Q66IC8, Q6F6B3, Q6P9H4, Q6ZMV9, Q76N33, Q7ZU92, Q7ZYZ7, Q8BHD4, Q8BML1, Q8BPM2, Q8IVH8, Q8IZC4, Q8K394

Diamond homologs: A2VDD2, Q32P71, Q3B8D7, Q4VYA0, Q54PG1, Q5JR98, Q66IC8, Q8CDY7, Q8N7M0, Q8WW35, Q9CQ66, Q9D5I4, F1QMY1, P11985, Q94524, Q9Z336, P63171, P63172

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

37 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance28
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

952 predictions. Top by Δscore:

VariantEffectΔscore
1:66752582:CAGGT:Cdonor_loss1.0000
1:66752583:AGG:Adonor_loss1.0000
1:66752584:GG:Gdonor_loss1.0000
1:66752585:GTA:Gdonor_loss1.0000
1:66754714:G:GTdonor_gain1.0000
1:66754776:GA:Gdonor_gain1.0000
1:66754778:G:GGdonor_gain1.0000
1:66770385:A:AGacceptor_gain1.0000
1:66770386:G:GAacceptor_gain1.0000
1:66770386:GTTCT:Gacceptor_gain1.0000
1:66770474:GTTGG:Gdonor_gain1.0000
1:66770475:T:Gdonor_gain1.0000
1:66776273:TTTCA:Tacceptor_loss1.0000
1:66776274:TTCA:Tacceptor_loss1.0000
1:66776275:TCA:Tacceptor_loss1.0000
1:66776276:CA:Cacceptor_loss1.0000
1:66776277:A:AGacceptor_gain1.0000
1:66776277:AGGTC:Aacceptor_loss1.0000
1:66776278:G:GAacceptor_gain1.0000
1:66776278:G:GTacceptor_loss1.0000
1:66776278:GGT:Gacceptor_gain1.0000
1:66776400:TGAGG:Tdonor_loss1.0000
1:66776401:GAG:Gdonor_gain1.0000
1:66776404:G:Cdonor_loss1.0000
1:66776405:T:Adonor_loss1.0000
1:66752586:T:Adonor_loss0.9900
1:66754775:AGA:Adonor_gain0.9900
1:66754776:GAG:Gdonor_gain0.9900
1:66770386:GTT:Gacceptor_gain0.9900
1:66776278:GGTC:Gacceptor_gain0.9900

AlphaMissense

1192 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:66777350:A:CS146R0.977
1:66777352:C:AS146R0.977
1:66777352:C:GS146R0.977
1:66777420:C:AA169D0.976
1:66777432:T:AV173D0.973
1:66777295:A:CK127N0.970
1:66777295:A:TK127N0.970
1:66777362:T:AW150R0.963
1:66777362:T:CW150R0.963
1:66777416:T:CF168L0.961
1:66777418:C:AF168L0.961
1:66777418:C:GF168L0.961
1:66777267:T:AV118D0.959
1:66776309:T:AV81D0.958
1:66777438:C:AA175E0.955
1:66777426:C:AA171E0.950
1:66777294:A:TK127I0.949
1:66777377:G:CD155H0.947
1:66777378:A:TD155V0.946
1:66777318:G:AG135E0.944
1:66777414:T:CL167P0.942
1:66777288:G:CR125P0.941
1:66776321:T:GL85W0.939
1:66777379:T:AD155E0.939
1:66777379:T:GD155E0.939
1:66777419:G:CA169P0.938
1:66777378:A:CD155A0.936
1:66777398:T:CF162L0.935
1:66777400:C:AF162L0.935
1:66777400:C:GF162L0.935

dbSNP variants (sampled 300 via entrez): RS1000030072 (1:66757361 T>A), RS1000152934 (1:66751192 C>A,T), RS1000210427 (1:66763310 G>A), RS1000342801 (1:66759760 A>G,T), RS1000398110 (1:66769849 C>T), RS1000429065 (1:66770161 T>C), RS1000664209 (1:66775320 T>G), RS1000678698 (1:66763489 T>A), RS1000679336 (1:66771569 C>A,T), RS1000730811 (1:66776773 A>G), RS1000765689 (1:66768708 G>A), RS1000772534 (1:66759424 A>G), RS1000894345 (1:66778708 G>C,T), RS1001200813 (1:66772002 A>G), RS1001247280 (1:66770765 G>A)

Disease associations

OMIM: gene MIM:619994 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST004131_16Inflammatory bowel disease5.000000e-111
GCST004132_7Crohn’s disease6.000000e-93
GCST004133_2Ulcerative colitis4.000000e-41

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
pirinixic acidaffects binding, decreases expression, increases activity1
CGP 52608affects binding, increases reaction1
belinostatincreases expression1
Decitabineaffects expression1
Acetaminophenincreases expression1
Air Pollutantsincreases abundance, increases expression1
Benzo(a)pyreneaffects methylation, increases methylation1
Cisplatinaffects expression1
Smokeincreases abundance, increases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoinincreases expression1
Triclosandecreases expression1
Antirheumatic Agentsdecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.